Sensei biotherapeutics to present new preclinical data at the society for immunotherapy of cancer (sitc) 37th annual meeting

Boston, oct. 05, 2022 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer, today announced it will present two posters at the society for immunotherapy of cancer (sitc) 37th annual meeting, being held in boston, ma from november 8 - 12, 2022.
SNSE Ratings Summary
SNSE Quant Ranking